According to the data, when microglia activity in the brain was suppressed, baby mice were better able to recall fearful experiences.

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune ...

Researchers suggest that wound dressings infused with antioxidants such as catalase could be an effective future treatment.

Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.

Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...

UC San Diego leads a $25.8 million ARPA-H funded project to 3D bioprint patient-specific human livers, aiming to eliminate organ shortages.